| Date Filed | Type | Description |
| 06/16/2023 |
SC 13D/A
| Nantahala Capital Management, LLC reports a 19.7% stake in AYTU BIOPHARMA, INC. |
| 05/26/2023 |
SC 13D
| Nantahala Capital Management, LLC reports a 7.2% stake in AYTU BIOPHARMA, INC. |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 9.9% stake in APOLLO ENDOSURGERY, INC. |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 5.4% stake in The RMR Group Inc. |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 9.9% stake in DarioHealth Corp. |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 8.8% stake in FALCONSTOR SOFTWARE, INC. |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 8% stake in Establishment Labs Holdings Inc. |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 9.9% stake in SOLENO THERAPEUTICS, INC. |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 9.2% stake in RumbleOn, Inc. |
| 02/14/2023 |
SC 13G
| Nantahala Capital Management, LLC reports a 7.9% stake in ABEONA THERAPEUTICS INC |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 12.7% stake in STRATA SKIN SCIENCES, INC. |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 6.2% stake in IDW Media Holdings, Inc. |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 3.7% stake in ALTA EQUIPMENT GROUP INC. |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 4.7% stake in Autolus Therapeutics plc |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 4.9% stake in IMMATICS N.V. |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 1.6% stake in Shift Technologies, Inc. |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 7.3% stake in FORTRESS BIOTECH, INC. |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 7.7% stake in DHI Group, Inc. |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 6.8% stake in Codexis, Inc. |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 6.1% stake in CIDARA THERAPEUTICS, INC. |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 7% stake in AVALO THERAPEUTICS, INC. |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 6.6% stake in APTOSE BIOSCIENCES INC. |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 7.5% stake in Acer Therapeutics Inc. |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 7.5% stake in AEGLEA BIOTHERAPEUTICS, INC. |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 8.3% stake in uniQure N.V. |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 8.9% stake in IMAX Corporation |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 8% stake in UNICYCIVE THERAPEUTICS, INC. |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 9% stake in Luxfer Holdings PLC |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 9.2% stake in RED VIOLET, INC. |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 6.9% stake in TravelCenters of America Inc. |
| 02/14/2023 |
SC 13G
| Nantahala Capital Management, LLC reports a 5.1% stake in BIOVENTUS INC. |
| 02/14/2023 |
SC 13G
| Nantahala Capital Management, LLC reports a 7% stake in Drive Shack Inc. |
| 02/14/2023 |
SC 13G
| Nantahala Capital Management, LLC reports a 7% stake in Lyra Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 0% stake in FINTECH ACQUISITION CORP. V |
|